Ixazomib: prices and alternatives
Ixazomib is indicated in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. It is not recommended for maintenance therapy or newly diagnosed multiple myeloma outside of controlled clinical trials.
3 products with this active ingredient from 1 manufacturer. Official prices from 40540 to 57375 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.


